Benzinga’s Top Ratings Upgrades, Downgrades For September 26, 2023
Upgrades According to Citigroup, the prior rating for Steel Dynamics Inc (NASDAQ:STLD) was changed from Neutral to Buy.…
Nike, Foot Locker, And Urban Outfitters Tread Carefully As Analyst Predict Sales Headwinds
After Urban Outfitters, Inc.
Benzinga’s Top Ratings Upgrades, Downgrades For September 25, 2023
Upgrades For Steel Dynamics Inc (NASDAQ:STLD), Citigroup upgraded the previous rating of Neutral to Buy. For the second…
Is Splunk A Good Investment After Cisco Deal Announcement? 7 Analysts Weigh In
Shares of Splunk Inc (NASDAQ: SPLK) rose in early trading on Thursday, after Cisco Systems Inc (NASDAQ: CSCO) announced its
Benzinga’s Top Ratings Upgrades, Downgrades For September 22, 2023
Upgrades For Agile Therapeutics Inc (NASDAQ:AGRX), Maxim Group upgraded the previous rating of Hold to Buy. For the…
ARS Pharmaceuticals’ EpiPen Alternative Delayed US Approval – Two Analysts Offer Differing Views
On Tuesday, The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for
Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics’ Prospects, Challenges
William Blair downgraded Travere Therapeutics Inc (NASDAQ: TVTX)
Benzinga’s Top Ratings Upgrades, Downgrades For September 21, 2023
Upgrades According to Truist Securities, the prior rating for International Paper Co (NYSE:IP) was changed from Hold to…
Benzinga’s Top Ratings Upgrades, Downgrades For September 20, 2023
Upgrades For Regency Centers Corp (NASDAQ:REG), Argus Research upgraded the previous rating of Hold to Buy. In the…
This Analyst Issues Sell Call On Tesla: Flags Demand Problems, Falling ASPs, And Margins
GLJ Research analyst Gordon L. Johnson II had a Sell rating on Tesla, Inc (NASDAQ: TSLA).